论文信息 - Analysis of biomarker expression (ki67, EGFR, HER2, ERK, NFkB, and mTOR) in patients with advanced gastric and gastroesophageal junction (GEJ) cancer treated with cetuximab plus cisplatin/docetaxel: DOCETUX study. - 字舞流文

Analysis of biomarker expression (ki67, EGFR, HER2, ERK, NFkB, and mTOR) in patients with advanced gastric and gastroesophageal junction (GEJ) cancer treated with cetuximab plus cisplatin/docetaxel: DOCETUX study.

C. Pinto | S. Siena | C. Ceccarelli | C. Barone | A. Martoni | S. Giaquinta | V. Mutri | F. R. Llimpe | F. Fabio | P. Tullio